Marciano Rodriguez Sablad

Title: Innovations by Marciano Rodriguez Sablad in the Treatment of OTC Deficiency

Introduction

Marciano Rodriguez Sablad is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of medical treatments, particularly in addressing genetic disorders. His innovative work focuses on developing effective therapies for ornithine transcarbamylase (OTC) deficiency.

Latest Patents

Marciano holds a patent for "Compositions and methods for the treatment of ornithine transcarbamylase deficiency." This patent describes compositions that include a lipid formulation and messenger RNA (mRNA) encoding an OTC enzyme. The lipid formulations can comprise an ionizable cationic lipid in a lipid nanoparticle encapsulating the mRNA. This innovative approach aims to provide a novel treatment for individuals suffering from OTC deficiency.

Career Highlights

Marciano Rodriguez Sablad is associated with Arcturus Therapeutics, Inc., a company dedicated to advancing RNA medicines. His work at Arcturus Therapeutics highlights his commitment to developing cutting-edge therapies that can significantly improve patient outcomes.

Collaborations

Marciano has collaborated with talented individuals such as Padmanabh Chivukula and Priya Prakash Karmali. These collaborations have contributed to the advancement of research and development in the field of genetic therapies.

Conclusion

Marciano Rodriguez Sablad's innovative work in the treatment of OTC deficiency showcases his dedication to improving healthcare through scientific advancements. His contributions are paving the way for new therapeutic options for patients in need.